✦ LIBER ✦

Adjuvant chemotherapy for advanced head and neck squamcus carcinoma: Final report of the head and neck contracts program

✍ Scribed by Bhadrasain Vikram; Charlotte Jacobs; Gregory Wolf; Robert Makuch

Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 133 KB
Volume: 12
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(86)90535-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant chemotherapy for advanced head

Adjuvant chemotherapy for advanced head and neck squamous carcinoma

✍ Final report of the head; neck contracts program 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 1016 KB

To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Insitute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982,462 patients with resectable Sta

Predictive factors for tumor response to

Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous carcinoma: The head and neck contracts program

✍ Gregory T. Wolf; Robert W. Makuch; Shan R. Baker 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

The high tumor response rates associated with intensive chemotherapy in previously untreated patients with advanced head and neck squamous cell carcinoma (HNSCC) led to the initiation of a multi-institutional National Cancer Institute trial. This trial used preoperative chemotherapy in patients with

Altered fractionation and adjuvant chemo

Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma

✍ William M. Mendenhall; Charles E. Riggs; Mikhail Vaysberg; Robert J. Amdur; John 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## Background The aim of this review was to discuss the role of altered fractionation and adjuvant chemotherapy for patients treated with definitive radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC). ## Methods This review explores the pertinent literature and discu

Preoperative adjuvant chemotherapy for a

Preoperative adjuvant chemotherapy for advanced head and neck cancer: A surgical evaluation

✍ John M. Loré JR; Juan A. Bonilla; Monica Spaulding; Keun Y. Lee; Sol Kaufman; Na 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 964 KB

This presentation consists of two parts: 1) a brief account of the results of treating 94 patients with stage 111 (n = 24) and stage IV (n = 70) advanced head and neck cancer, primarily with two courses of preoperative adjuvant chemotherapy; and 2) an evaluation of 42 of the 94 patients consecutivel

Combination chemotherapy for advanced sq

Combination chemotherapy for advanced squamous cell carcinoma of the head and neck

✍ Coker, Donald D. ;Elias, E. George ;Chretien, Paul B. ;Gray, William C. ;Coleman 📂 Article 📅 1981 🏛 Wiley (John Wiley & Sons) ⚖ 639 KB

## Abstract Fifty‐one patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__‐platinum (DDP), bleomycin (Bleo), ± high dose methotrexate (MTX). Thirty‐th

DNA measurements for monitoring chemothe

DNA measurements for monitoring chemotherapy in advanced head and neck carcinomas

✍ Dr. Hans J. Welkoborsky; Dr. Wolf J. Mann; Dr. Cem Sanal; Dr. James E. Freije 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

Background. Quantitative DNA measurements have demonstrated prognostic relevance in various malignancies, including head and neck cancer. The application of DNA measurements in monitoring and predicting the outcome of chemotherapy in treating patients with head and neck cancer was investigated. Met